Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
At close: Nov 20, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $53.25 thousand as of November 20, 2026. It is the 51,417th most valuable company in the world and the 7,351st biggest in the United States. Its market cap has decreased by 99.14% in one year.
Market Cap
53.25K
Enterprise Value
14.42M
Revenue
398.00K
Global Rank
Country Rank
#7,351 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 53.25K, a decrease of -99.98%. That is a compound annual growth rate of -72.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 53.25K | -99.03% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Synairgen | 110.27K |
| Innovation Pharmaceuticals | 105.75K |
| Ocean Biomedical | 92.95K |
| Vincerx Pharma | 83.75K |
| Entia Biosciences | 78.34K |
| PaxMedica | 63.14K |
| Affymax | 59.59K |
| GB Sciences | 52.94K |